CPPD


Also found in: Acronyms.

CPPD

CPPD

calcium pyrophosphate dihydrate.

CPPD

abbrev. for calcium pysophosphate dihydrate, the crystalline substance deposited in cartilage and causing PSEUDOGOUT.
References in periodicals archive ?
The drug allopurinol can treat the cause of gout (high uric acid levels), but no such medication is available to reduce CPPD. Pseudogout attacks usually are treated with anti-inflammatory medications, including colchicine and nonsteroidal anti-inflammatory drugs.
A variety of comorbidities and metabolic conditions have been recognized to predispose to CPPD (Table 1).
An acute episode of CPPD disease may occur spontaneously or develop after trauma, surgery or a severe medical illness, similar to an attack of gout.
The diagnosis of CPPD was confirmed and he was advised to take an antiinflammatory if symptoms recurred and booked for further follow-up in six months.
(a) This fluorescent image depicts NETs released from human PMNs following CPPD crystal stimulation (50 [micro]g/mL, 3 hrs, unpublished data).
Asi, tambien, en el caso de la CPPD, se produjo en 2005 una reversion de la tendencia observada hasta 1999, al obtener mas apoyo entre las mujeres que entre los hombres.
CPPD coordinator and CPH associate professor Dr Nadir Kheir said: "We are proud to receive such an honour for this programme that continues to grow and have such a strong and valuable impact on the pharmacy and healthcare sector in Qatar.
SODFIC may have attended the Center for Personal and Professional Development (CPPD) courses outside of the Navy Supply Corps School (NSCS) which include:
Las principales complicaciones neurologicas asociadas a los bloqueos neuroaxiales, especialmente la anestesia raquidea, epidural o ARE, son: cefalea pospuncion dural (CPPD), dano neurologico y complicaciones cardiovasculares tales como hipotension, bradicardia o paro cardiaco (13-40).
These breakthroughs in the field of gout have given a new insight into other crystal-induced arthropathies [3] and recent international guidelines have been produced for both the treatment of gout [4, 5] and calcium pyrophosphate deposition (CPPD) [6].
Considering this, targeting GM-CSF could also be promising in gout or calcium pyrophosphate deposition disease (CPPD).